Altering the balance between immune activation versus regulation in the skin to promote CD8+ T-cell activity within epithelial cancers

Jennifer A. Bridge, Nana Haahr Overgaard, Raymond Steptoe, Ian H. Frazer, James W. Wells

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

    111 Downloads (Pure)


    The Human Papilloma Virus (HPV) 16 is a high-risk HPV known to be a causative agent in numerous cancers including cervical cancer. While prophylactic vaccines exist to combat the spread of HPV16, successful therapeutic vaccines to combat established HPV16-associcated disease remain elusive. The expression, in a mouse model (“E7”), of the HPV16 E7 gene in keratinocytes under the control of the K14 promoter, leads to a local immune suppressive environment, as evidenced by the lack of graft rejection when E7 skin grafts are placed on WT recipient mice. Furthermore, well healed (>30 days) E7 skin grafts are not rejected when mice are immunised with E7 peptide in combination with Quil A- or CASAC-based adjuvants. This is despite a substantial increase in E7 peptide/H-2Db pentamer staining in the blood, and marked killing of E7-peptide expressing TC-1 cells when injected i.v., confirming that CD8 T-cells respond to vaccination and differentiate into CTL capable of killing E7-expressing target cells. We hypothesised that the removal of regulatory T-cells (T-reg) might lead to E7 graft rejection in immunised mice. The co-administration of an anti-CD4-depeting antibody at the time of immunisation led to rejection of ~50% of grafts. To confirm a role for T-reg, E7-grafted T-reg-deficient Rag1-/- mice received purified donor CD8 T-cells from E7-vaccinated WT mice. FACS staining of Rag1-/- lymph nodes 30 days post CD8+ T-cell transfer confirmed the absence of classical CD4+FoxP3+ Treg, however the E7 grafts did not reject. As in the WT mice however, rejection could be induced through the coadministration of an anti-CD4 antibody. The data suggest that the removal of a CD4+, non T-reg cell, leads to CD8+ T-cell activity in the skin as evidenced by E7 skin graft destruction.
    Original languageEnglish
    Publication date2016
    Number of pages1
    Publication statusPublished - 2016
    EventAmerican Association for Cancer Research (AACR) Annual Meeting 2016 - New Orleans, Louisiana, United States
    Duration: 16 Apr 201620 Apr 2016


    ConferenceAmerican Association for Cancer Research (AACR) Annual Meeting 2016
    CountryUnited States
    CityNew Orleans, Louisiana

    Fingerprint Dive into the research topics of 'Altering the balance between immune activation versus regulation in the skin to promote CD8+ T-cell activity within epithelial cancers'. Together they form a unique fingerprint.

    Cite this